EverPoint Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-210,800
Closed -$6.46M 504
2015
Q4
$6.46M Sell
210,800
-843,200
-80% -$26.5M 0.14% 207
2015
Q3
$31.4M Buy
1,054,000
+579,700
+122% +$18.6M 0.81% 24
2015
Q2
$15.1M Buy
+474,300
New +$15.5M 0.28% 107

Other funds holding PFE

EverPoint Asset Management's PFE Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Pfizer (PFE) in Q4 2016: 368,900 shares worth $11.4M. The stake represents 0.21% of the portfolio and ranks #129 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in PFE as recently as Q4 2014.

EverPoint Asset Management first reported a position in PFE in Q4 2014 and has held it in 2 quarters since. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • EverPoint Asset Management held 368,900 shares of Pfizer worth $11.4M as of Q4 2016.
  • Pfizer was a new EverPoint Asset Management position in Q4 2016.
  • Pfizer made up 0.21% of EverPoint Asset Management's portfolio in Q4 2016, its #129 holding.
  • EverPoint Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 2 quarters since.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.